Novartis announces completion of transactions with GSK
Completes transactions with GSK including: acquisition of GSK oncology portfolio, creation of Consumer Healthcare joint…
05/03/2015 - 5 minutes
Completes transactions with GSK including: acquisition of GSK oncology portfolio, creation of Consumer Healthcare joint…
Celltrion Healthcare has today announced the launch of Remsima (infliximab) in 12 European markets: Austria,…
GSK, who was already a minority shareholder in GlycoVaxyn, acquires the company and its biological…
Six years ago, a new sophisticated prokaryotic defense system, was identified in the structure complex…
Novartis divests its influenza vaccines business to CSL Limited, an Australian company, for an agreed…
The deal for the sale of Gamida Cell to Novartis is back on. Instead of a huge exit…